Online citations, reference lists, and bibliographies.
← Back to Search

Evaluation Of Src Tyr419 As A Predictive Biomarker In A Neoadjuvant Trial Using Dasatinib In Resectable Malignant Pleural Mesothelioma.

A. S. Tsao, I. I. Wistuba, R. J. Mehran, J. Gil, M. Nunez, J. Lee, H. Lin, S. M. Lippman, W. K. Hong

Save to my Library
Download PDF
Analyze on Scholarcy
Share